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The Journal of Immunology
IgG1 Is Required for Optimal Protection after Immunization
with the Purified Porin OmpD from Salmonella Typhimurium
Yang Zhang,* Coral Dominguez-Medina,* Nicola J. Cumley,† Jennifer N. Heath,*
Sarah J. Essex,‡ Saeeda Bobat,* Anna Schager,* Margaret Goodall,* Sven Kracker,x,1
Christopher D. Buckley,* Robin C. May,† Robert A. Kingsley,{ Calman A. MacLennan,*
Constantino Lo´pez-Macı´as,‖ Adam F. Cunningham,*,# and Kai-Michael Toellner*
In mice, the IgG subclass induced after Ag encounter can reflect the nature of the Ag. Th2 Ags such as alum-precipitated proteins
and helminths induce IgG1, whereas Th1 Ags, such as Salmonella Typhimurium, predominantly induce IgG2a. The contribution of
different IgG isotypes to protection against bacteria such as S. Typhimurium is unclear, although as IgG2a is induced by natural
infection, it is assumed this isotype is important. Previously, we have shown that purified S. Typhimurium porins including outer
membrane protein OmpD, which induce both IgG1 and IgG2a in mice, provide protection to S. Typhimurium infection via Ab. In
this study we report the unexpected finding that mice lacking IgG1, but not IgG2a, are substantially less protected after porin
immunization than wild-type controls. IgG1-deficient mice produce more porin-specific IgG2a, resulting in total IgG levels that
are similar to wild-type mice. The decreased protection in IgG1-deficient mice correlates with less efficient bacterial opsonization
and uptake by macrophages, and this reflects the low binding of outer membrane protein OmpD–specific IgG2a to the bacterial
surface. Thus, the Th2-associated isotype IgG1 can play a role in protection against Th1-associated organisms such as S.
Typhimurium. Therefore, individual IgG subclasses to a single Ag can provide different levels of protection and the IgG isotype
induced may need to be a consideration when designing vaccines and immunization strategies. The Journal of Immunology, 2017,
199: 000–000.
P
athogen-specific Ab is the critical factor conferring im-
munity in response to most vaccines. IgG-switched Ab is
often measured as the main mediator of immunity and is
often sufficient to confer protection after passive vaccination. IgG
can work through neutralization, through binding complement, and
through the activation of a range of Fcg receptors. These activities
show some variability depending upon which isotype of IgG is
being examined. Different IgG isotypes of man and mouse are not
evolutionary homologs, but there are similarities in some features
such as a similar diversity in flexibility or different capacities to
interact with activating and inhibitory Fc receptors and comple-
ment (1). Therefore, an IgG response involving multiple isotypes
can lead to a complex network of modulatory effects mediated by
a range of different IgG subclasses.
In mice, the direction of IgG switching can reflect the polari-
zation of the Th cell response, which is determined by the nature of
the immunizing Ag (2). Immunization with soluble flagellin, most
pure proteins precipitated on alum, or helminths such as Nippos-
trongylus brasiliensis induces a strong Th type 2 response with
class switching to IgG1 and little detectable IgG2a (3, 4). The
induction of IgG1, in vitro, is strongly dependent upon IL-4, but
in vivo this is not essential (5). Murine IgG1 has a modest capacity
to bind C1q and because it binds weakly to FcgRIIB and FcgRIII,
it is not associated with promoting strong activation of immune
responses in host immune cells (6, 7). Therefore, IgG1 is not
considered to play significant roles in protection against intra-
cellular bacterial infections, although IgG1 promotes protection
against other pathogens, e.g., Cryptococcus neoformans (8).
Infection with live Gram-negative bacteria such as Salmonella
enterica serovar Typhimurium induces Th1 immunity with less
IgG1 and dominant switching to IgG2a, associated with the
transcription factor T-Bet (9). Because Ab induced after natural
infection with S. Typhimurium can protect, it seems reasonable to
assume that Th1-associated IgG isotypes, such as IgG2a, play a
key role in this protection.
Immunization with the porin protein outer membrane protein
OmpD (OmpD) from S. Typhimurium can provide Ab-mediated
protection against infection, with IgG contributing the majority of
this effect (10). Immunization with purified porins confers im-
munity to S. Typhimurium infection and induces both IgG1 and
IgG2a (11). It is not clear whether different isotypes contribute
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equally to protection. In this study we have tested the requirement
for IgG1 for protection against S. Typhimurium infection after
immunization with OmpD. Unexpectedly, we identify a key role
for IgG1 in mediating vaccine-induced protection from infection.
Materials and Methods
Mice
Sex-matched 6–12 wk old C57BL/6 mice were obtained from Harlan
Laboratories (Bicester, U.K.). hMt mice with a targeted deletion of the
splice site of IgG1 H chain germline transcripts are unable to class switch
to IgG1-deficient hMt mice (IgG1ko) (12), T-bet–deficient mice (T-betKO)
(13), and mice in which the Cre-coding sequence was inserted into the 39
region of the Cg1 locus (Cg1-Cre) (14) were bred in house. Animal studies
were performed with the approval of local ethical committees and under
Home Office license.
Bacterial strains, immunizations, infections, and opsonization
of bacteria
S. Typhimurium SL3261 is an attenuated mutant of the laboratory strain
SL1344 (15). S. Typhimurium SL3261 expressing GFP was generated by
inserting the eGFP gene into the pettac plasmid, which has a modified tac
promoter to enable constitutive gene expression, as described previously
(16). S. Typhimurium SL1344 deficient for OmpF and OmpC (ompC::aph
ompF::cat) was used as the bacterial source of OmpD (10); S. Typhimurium
D23580 is a virulent, representative isolate of an invasive S. Typhimurium
strain from sub-Saharan Africa (17). S. Typhimurium D23580 deficient for
wbaP are unable to make LPS containing O-Ag. Genetically altered strains
were generated by P22 transduction using standard methods (18).
OmpD preparations from S. Typhimurium were made by 2% (v/v)
Triton X-100 extraction (19) and repeated extraction with SDS and sepa-
ration by fast protein liquid chromatography on a Sephacryl S-200 column
before dialysis against PBS/0.1% (w/v) SDS (10, 20). By SDS-PAGE with
detection of protein by Gelcode Blue, OmpD is a single band and the
limulus assay estimates endotoxin contamination to be typically one en-
dotoxin unit per 30 mg of OmpD. Mice were primed with 20 mg OmpD in
PBS i.p. Then 5 wk later, mice were infected with 53 105 S. Typhimurium
i.p. In some experiments mice were boosted with 20 mg OmpD
i.p., followed by infection 14 d later. To obtain OmpD-specific sera,
C57BL/6 mice were immunized with 20 mg of OmpD via i.p., boosted on
days 14 and 28, and then sacrificed at day 35. Infections with opsonized
bacteria were performed as described previously (21), opsonizing with
sera from wild-type (WT) and IgG1ko mice that had been primed and
boosted with OmpD and infected with S. Typhimurium for 5 d. Sera from
S. Typhimurium–immune mice were matched to contain similar concen-
trations of OmpD-specific IgG. Sera were heat inactivated at 56˚C for
30 min. Then bacteria (2.5 3 106 per ml) and sera (diluted 1:100) were
mixed for 30 min and opsonized bacteria were injected into mice i.p.
Viability and bacterial aggregation of opsonized bacteria was confirmed to
be unaffected by opsonization. Adoptive transfer of serum was performed
by injecting 120 ml of sera i.p. into mice 24 h before infection. These sera
were from WT or IgG1ko mice immunized twice with OmpD, and had
similar levels of total anti-OmpD IgG Ab titers. Tissues were harvested
postinfection and bacterial burdens were determined by serial dilution
culture of homogenized tissue.
Immunohistology
Immunohistology was performed on frozen sections as described previously
(22). Briefly, acetone-fixed frozen spleen sections (6 mm) were stained
using rat anti-mouse IgD (BD Biosciences, Oxford, U.K.), sheep anti-
mouse IgD (Abcam, Cambridge, U.K.), rat anti-mouse IgG1, IgG3,
IgG2a/c (AbD Serotec, Oxford, U.K.), or 4-hydroxy-nitrophenyl (NP)
conjugated to sheep Ig. Secondary Abs (rabbit anti-rat Ig or donkey anti-
sheep Ig) conjugated to biotin or HRP were applied. The biotinylated
secondary Abs were detected using biotin-conjugated StreptABComplex-
alkaline phosphatase complex (Dako, Ely, U.K.). In the final step, color was
developed using FastBlue and 3,39-diaminobenzidine (Sigma-Aldrich). The
area of the spleen occupied by germinal centers (GCs) and cells per square
millimeter was calculated using a point-counting technique as described pre-
viously (22, 23).
ELISA
ELISAs were performed as previously described to detect serum Abs to NP,
Salmonella bacteria, or OmpD (19). Plates were coated with Ag at 5 mg/ml
overnight. NP15-BSA–coupled plates were used to detect NP-specific Ab;
NP2-BSA–coupled plates were used to measure the high-affinity Ab
fraction. Relative affinity was calculated by dividing relative Ab concen-
tration from NP2-BSA–coupled plates by the concentration derived from
NP15-BSA–coupled plates. Alkaline-phosphatase–labeled secondary Abs
to IgG (cat: 1030-04), IgG1 (cat: 1070-04), and IgG2a/c (cat: 1080-04),
IgG3 (cat: 1079-04), and IgM (1020-04) were purchased from Southern
Biotech. The absorbance at OD405 nm was determined using an Emax
microplate spectrophotometer (Molecular Devices, Biberach an der Riss,
Germany). Relative reciprocal titers were calculated by measuring the
dilution at which the serum reached a defined OD405 nm.
In vitro macrophage uptake assay
The semiadherent macrophage-like cell line J774 (24) was used in this assay,
which was performed as described previously (25). S. Typhimurium–GFP
bacteria were opsonized with WT or IgG1ko sera as describe above.
Opsonized bacteria were mixed with macrophages in a 5:1 ratio, grown on
glass coverslips in serum-free RPMI 1640 medium, and incubated at 37˚C
for 1 h. Nonadherent bacteria were washed off with PBS 1 h later, and fixed
in 4% paraformaldehyde. The coverslips were mounted on microscope
slides and visualized on a Zeiss LSM 510 Meta confocal with 1003 lens.
Fluorescence photomicrographs were taken with a Leica DM6000 with
filters suitable for GFP detection. Macrophage cell bodies were segmented
using ImageJ/Fiji image analysis software (26) by thresholding the auto-
fluorescent signal obtained at 600 6 20 nm after 546 nm excitation. The
percentage of macrophage area covered by GFP was calculated from
.1000 cells per sample.
Statistics
Statistical analysis was carried out using Prism 6. Groups were compared
using unpaired t test or Mann–Whitney U test as indicated in the figure
legends. Correlations were tested using the Spearman rho test. Statistics
throughout were carried out by pooling data from all independent exper-
iments. The p values are indicated throughout with *p , 0.05, **p , 0.01,
***p , 0.001, and ****p , 0.0001.
Results
IgG1-deficient mice respond normally to alum-precipitated
proteins or live S. Typhimurium
Immunization with purified alum-precipitated proteins preferen-
tially induces IgG1 (2). To test how an inability to produce IgG1
affects the Ab response to protein, IgG1ko and WT mice were
immunized with alum-precipitated NP coupled to chicken g glob-
ulin (CGG). Then 14 d postimmunization IgG1ko spleens contained
NP-specific GCs of comparable number, size, and morphology as
WT spleens (Fig. 1A, 1B). B cells in these GCs express IgG sub-
classes other than IgG1, including IgG3 (Fig. 1A, 1B). Then 5 wk
postimmunization, IgG1ko spleens contained similar numbers of
NP-specific plasma cells, but increased numbers of plasma cells
expressing IgG2a (Fig. 1C). Whereas serum levels of NP-specific
IgM were similar (data not shown), Ag-specific IgG3 and IgG2a
levels were increased in the absence of IgG1 (Fig. 1D). No sig-
nificant changes in the amounts of Ag-specific IgE produced and no
change in the overall affinity of IgG compared with WT mice were
observed (Fig. 1E). Nor could we detect changes in the extent of
B and T cell reactivation or Th2-type cytokine production after
secondary challenge with the same Ag (data not shown). This shows
that affinity maturation and GC differentiation function normally in
IgG1ko mice, with class-switching to other isotypes compensating
for the loss of IgG1.
We have previously described that the primary Ab response
postinfection with live S. Typhimurium bacteria induces few
splenic IgG1-switched plasma cells and minimal levels of Ag-
specific IgG1 to outer membrane Ags (19, 27). This means it
differs markedly from the responses to protein Ags in alum or
after vaccination with purified porin proteins like OmpD, where
Ag-specific responses are readily detectable (2, 27). To confirm
that IgG1 does not play a major role during primary infection with
S. Typhimurium, we infected IgG1ko mice with S. Typhimurium.
IgG1ko mice had similar levels of splenomegaly and bacterial
2 ROLE OF IgG1 TO OmpD IN IMMUNITY TO SALMONELLA
 by guest on N
ovem
ber 12, 2017
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
burdens in the first week of infection, showing they control the
infection to a comparable level (Fig. 2A). IgG2a-switched plasma-
blast induction at 7 d postinfection was similar in both groups
(Fig. 2B). Thus, although loss of IgG1 results in a distinct IgG
isotype profile, the quality of the primary Ab response to immuni-
zation with protein as well as primary infection with S. Typhimurium
is unaltered.
Protection to S. Typhimurium induced after immunization with
OmpD requires IgG1
To investigate whether IgG1 aids protection against S. Typhimu-
rium infection after immunization, WT and IgG1ko mice were
primed with OmpD purified from S. Typhimurium, which can
provide Ab-dependent protection in WT mice (10). Then, 5 wk
after primary immunization mice were challenged with 5 3 105 S.
Typhimurium and bacterial burdens assessed 5 d later. Surpris-
ingly, immunized IgG1ko mice were less protected than control
mice, with spleens substantially larger (Fig. 2C) and bacterial
counts in the liver and spleen higher than in WT mice (Fig. 2C).
This indicates that IgG1 is important for the control of S. Typhi-
murium infection in OmpD-immunized mice.
A second immunization with protein Ags should lead to in-
creased levels and higher affinity of OmpD-specific Ab. To test
whether a further immunization can compensate for the absence of
IgG1, WT and IgG1ko mice were reimmunized with OmpD before
challenge with S. Typhimurium. OmpD-specific IgM and overall
IgG levels were similar between WT and IgG1ko mice throughout
this response. Similar to what is seen in responses to NP-CGG,
IgG1ko mice compensate for the loss of IgG1 through higher
levels of IgG2a (Fig. 3A). OmpD-specific IgG3 titers were similar
between both groups (Fig. 3B). Challenge with live S. Typhimu-
rium did not lead to a change in the bias toward IgG1 (Fig. 3A).
Assessing bacterial numbers in spleen 5 d postinfection showed that
prime-boosted IgG1ko mice also had splenic bacterial burdens
.20-fold higher than WT mice (Fig. 3C), indicating the additional
Ab induced is not sufficient to compensate for the loss of IgG1.
To test protection in animals expressing a wider range of Ag-
specific IgG1 and IgG2a titers, we used the same immunization
and challenge protocol with Cg1-Cre mice, which can switch to
IgG1 but at much reduced levels (14). We then correlated bacterial
burdens against Ab titers. This showed that the level of protection
from S. Typhimurium infection correlated with OmpD-specific
IgG1, but not with other Ig classes (Fig. 3D). Thus, IgG1 is
needed for optimal protection after immunization with OmpD and
the level of specific IgG1 induced correlates with the level of
protection.
FIGURE 1. IgG1 deficiency does not affect the
extent and affinity of the responses after immuni-
zation with T dependent Ag. (A) Two adjacent
spleen sections from IgG1ko mice showing NP-
specific GCs with B cells switched to IgG3; 2 wk
after immunization with NP-CGG. Scale bar,
100 mm. (B) Size and extent of Ag-specific GCs
and GCs containing IgG1- or IgG3-switched
B cells in spleens from WT (s) or IgG1ko (♦)
mice. (C) Numbers of NP-specific plasma cells or
plasma cells switched to different IgG isotypes in
splenic red pulp. (D) Relative amount of total or
high-affinity NP-specific Ab of different IgG sub-
classes in mice before or 5 wk after immunization
with NP-CGG. (E) Relative affinity of Ag-specific
sera shown in (D). Broken horizontal line: detection
level. Each symbol represents one animal. Statis-
tical analysis of cell numbers was carried out using
a two-tailed t test, whereas analysis of Ab titers was
carried out using a one-tailed Mann–Whitney
U test. Experiments were repeated twice with
groups containing four mice per group. *p , 0.05.
n.d., not detectable; TZ, T cell zone.
FIGURE 2. Effect of IgG1 deficiency on S. Typhimurium infection. WT
(white bars) and IgG1ko (black bars) mice were infected i.p. with 5 3 105
S. Typhimurium. (A) Spleen mass of naive IgG1ko and WT mice before
and 7 d after primary S. Typhimurium infection, and bacterial burden in
spleen and liver. (B) IgG2a-switched plasma cells in spleens of naive mice
before and 7 d postinfection. (C) Effect of S. Typhimurium infection on
naive or OmpD-vaccinated WT and IgG1ko mice. Then 35 d after vacci-
nation with 20 mg OmpD mice were challenged with of 5 3 105
S. Typhimurium. Responses assessed 5 d postinfection. Spleen mass and
bacterial CFU in spleen and liver. Linear scale bar charts show arithmetic
mean with SD. Logarithmic bar charts show geometric mean with 95%
confidence limits. Data analyzed by two-tailed t test. Data are represen-
tative of two to three independent experiments with groups containing at
least four mice per group. ***p , 0.001, ****p , 0.0001.
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IgG2a is not essential for protection after immunization
with OmpD
IgG2a is induced after natural infection with S. Typhimurium and
therefore may contribute to protection. To test this, WT, IgG1ko,
and T-betKO mice (which do not produce IgG2a) were immunized
with OmpD and challenged with S. Typhimurium 35 d later
(Fig. 4A). Immunization induced similar IgG1 titers in the WT and
T-betKO mice. As expected, IgG2a was not detectable in T-betKO
mice (Fig. 4A). Comparing OmpD-specific IgG subclass levels
and bacterial burdens showed a clear negative correlation with
Ag-specific IgG1, but not IgG2a levels (Fig. 4B). This is consis-
tent with IgG1 having an important role for protection after im-
munization with OmpD but IgG2a being less important.
IgG1 promotes bacterial adhesion and uptake by phagocytes
We then examinedwhether the Ab itself fromOmpD-immunizedmice
was responsible for these effects. To do this, sera fromWT, IgG1ko, or
T-betKO mice (all immunized twice with OmpD) were matched to
ensure the OmpD-specific total IgG titers were comparable. Sera were
heat treated to inactivate complement. Bacteria were then opsonized
with these sera and with control sera from nonimmunized WT mice
and mice were infected with these opsonized bacteria. Opsonization
with sera from OmpD-immunized WT or T-betKO mice led to an
approximate 100-fold lower number of bacteria in spleens than in-
fection with bacteria incubated with nonimmune sera (Fig. 5A).
In contrast, bacterial numbers in spleens of mice infected with
S. Typhimurium opsonized with IgG1-deficient sera were
∼10-fold higher than in mice that received S. Typhimurium
opsonized with OmpD-specific sera from WT or T-betKO mice
(Fig. 5A). Similarly, transfer of OmpD-specific serum from WT or
IgG1ko mice into naive recipients 1 d before challenge with
S. Typhimurium led to reduced protection if IgG1 was absent (Fig. 5B).
In mice, killing of S. Typhimurium is strongly reliant upon cell-
dependent mechanisms through enhancing bacterial uptake by
phagocytes (28, 29). To test whether loss of IgG1 affected bac-
terial uptake by macrophages, S. Typhimurium–expressing GFP
were opsonized with sera from naive or OmpD-immunized WT or
IgG1ko mice, which were matched to have similar total anti-
OmpD–specific IgG titers. Opsonized bacteria were then incu-
bated in vitro with the murine macrophage cell line J774 and
attachment and uptake of bacteria by macrophages assessed by
confocal microscopy. This showed bacteria in contact with and
apparently ingested by macrophages (Fig. 5C). Quantification of
the bacteria associated with phagocytes revealed fewer bacteria
colocalized with macrophages when IgG1 was absent (Fig. 5D,
5E). This suggests that opsonization of bacteria by IgG1 promotes
the binding and uptake of bacteria by phagocytes.
IgG2a shows poor binding to OmpD in its natural context on
the bacterial surface
The earlier experiments demonstrate that IgG1 and IgG2a, al-
though both able to bind to purified OmpD protein (Fig. 3A), do not
FIGURE 3. Protection from S. Typhimurium infection
correlates with IgG1 levels. (A) WT (s), or IgG1ko (♦)
mice were vaccinated with 20 mg OmpD and boosted at
day 35 for 14 d before being infected i.p. with 5 3 105
S. Typhimurium. Relative levels of OmpD-specific IgM,
IgG, IgG1, and IgG2a in sera assessed by ELISA. (B)
Relative levels of OmpD-specific IgG3 in sera from mice
14 d after a second immunization with OmpD and prior to
infection. Statistical analysis using one-tailed Mann–
Whitney U test. Broken line: detection level. (C) Bacterial
numbers in spleens in the same mice 5 d postinfection
with S. Typhimurium. Statistical analysis was carried us-
ing two-tailed Student t test from data of two independent
experiments. Bars and whiskers indicate geometric mean
and 95% confidence limits. (D) Correlation of OmpD-
specific serum Ab levels of different Ig classes before
infection and matched splenic bacterial count 5 d post-
infection. WT (s), IgG1ko (♦), and Cg1-Cre (Δ) mice
vaccinated and infected as in (A). Statistical analysis was
performed using the Spearman rho test. Data plotted are
from two independent experiments, with five mice in each
group. Each symbol corresponds to one animal. *p , 0.05,
**p , 0.01, ***p , 0.001, ****p , 0.0001. ns, not
significant.
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offer equivalent protection. One explanation for this is that the
different IgG isotypes may not bind equally well to OmpD when it
is found in its natural context on the bacterial surface. To test
whether IgG1 and IgG2a are able to bind OmpD on the surface of
intact bacteria, ELISAs were performed using free OmpD, or two
different strains of intact S. Typhimurium bacteria (the laboratory
strain SL1344 and the clinical African isolate D23580; Fig. 6A).
This showed that, whereas IgG1 bound to ELISA plates coupled
with intact bacteria and with purified OmpD, binding of IgG2a to
intact bacteria was undetectable (Fig. 6A). To test whether the
presence of LPS O-Ag may impede binding of IgG2a to OmpD,
binding of total IgG, IgG1, and IgG2a to plates coated with free
OmpD, whole, intact WT S. Typhimurium bacteria and whole,
intact O-Ag–deficient S. Typhimurium were tested. This showed
that more binding of IgG2a was detected if O-Ag was absent
(Fig. 6B). Thus, OmpD-specific IgG2a is less capable of binding
to WT bacteria than IgG1.
Discussion
In this study we identify a significant role for IgG1 in the protection
mediated by an experimental vaccine against nontyphoidal Sal-
monella infections. The requirement for IgG1 in such responses is
surprising because infection with S. Typhimurium in mice pri-
marily induces IgG2a. Experimental studies in mice suggest that
after natural infection the immunodominant target of protective
Ab is the serovar-specific O-Ag of LPS (30). Thus, IgG2a to LPS
O-Ag may provide more effective protection than it does to
OmpD. Indeed, work examining the capacity of monoclonal Abs
to LPS O-Ag supports this concept, although it is of significance
that monoclonal Abs that were of an IgG1 isotype also provided
protection (31). Purified OmpD induces robust IgG responses of
all four IgG isotypes in mice and long-lasting IgG responses in
FIGURE 4. Protection after OmpD immunization is maintained in the
absence of IgG2a. WT, IgG1ko, and T-betKO were immunized with OmpD
and challenged with S. Typhimurium at day 35. (A) OmpD-specific IgG1
and IgG2a levels prior to challenge and 5 d postinfection with S. Typhi-
murium. (B) Matched OmpD-specific IgG1 and IgG2a serum levels prior
to challenge with S. Typhimurium and splenic bacterial numbers 5 d after
challenge. Statistical analysis performed using the Spearman rho test. Data
plotted are from two independent experiments, with groups each con-
taining five mice. Each symbol corresponds to one animal. Broken hori-
zontal line: detection level. *p , 0.05, ***p , 0.001. ns, not significant.
FIGURE 5. IgG1 promotes the association of bacteria and phagocytes.
(A) B cell–deficient mice were infected with S. Typhimurium opsonized
with sera from nonimmune (NI) or OmpD-immunized WT, T-betKO, or
IgG1ko mice (matched to contain similar levels of OmpD-specific IgG).
Splenic bacterial numbers were quantified 5 d postinfection. Each symbol
corresponds to one mouse. Statistical analysis using two-tailed t test. (B)
WT mice were injected with sera from OmpD-immunized WT or IgG1ko
mice (matched to contain similar levels of OmpD-specific total IgG) or no
sera (NS), and 24 hr later infected with S. Typhimurium SL3261. Splenic
bacterial numbers were quantified 5 d postinfection. (C) Apical and lateral
view of a J774 macrophage after 1 h culture with GFP-expressing
S. Typhimurium opsonized with OmpD-specific sera from a WT mouse.
Green, S. Typhimurium–GFP; red, autofluorescence. (D) Overview fluo-
rescence micrographs of J774 cells incubated with GFP-expressing
S. Typhimurium opsonized with OmpD-specific WT or IgG1ko sera. (E)
Quantification of S. Typhimurium uptake from macrophages incubated
with S. Typhimurium not opsonized or incubated with Ag-naive WT serum
(NI) or immune WT or IgG1ko serum. Bars show mean and SD derived
from .10 microphotographs per sample. In (A) and (B), each group
contained at least three mice and are shown from three experiments, except
for (B), which was performed once. In (C)–(E), data are representative of
three independent experiments, with signal strength calculated from
.1000 cells analyzed for each condition. Statistical analysis using two-
tailed t test, ***p , 0.001, ****p , 0.0001.
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humans (32), although the isotypes induced by Salmonella OmpD
in humans have not been assessed. The effects observed in the
IgG1ko mice are unlikely to be due to non-Ab mechanisms of
B cells, which can promote protection, as opsonizing bacteria with
Ab prior to infection was sufficient to reproduce the defect in
protection (33, 34). This supports the wealth of evidence showing
an important role for Ab in protecting against Salmonella infec-
tions, although this protection is not complete as both T and B cell
elements are required for full protection (10, 19, 21, 30, 35, 36).
Our study refines our understanding of the role of IgG in pro-
tection to highlight the necessity to consider the requirement for
different isotypes to different Ags in this protection.
Different IgG isotypes may make distinct contributions to
protection dependent upon a number of factors, some of which are
related to the intrinsic properties of the Ab isotype and some to the
intrinsic nature and properties of the Ag. In humans this can be
exemplified by examining the positive and negative roles of IgG2.
For instance, examining the response to LPS O-Ag in human in-
fections we have shown that the amount of Ab to O-Ag can in-
fluence the level of killing that Ab can promote (37–39). Moreover,
when anti-LPS O-Ag IgG is present in supra-physiological
amounts, it can inhibit bactericidal activity of Ab in cell-
dependent and independent systems (38). Indeed, removing such
inhibitory Abs may show clear patient benefit in some circum-
stances (39). This is likely to reflect an imbalance between the
amounts of Ab present and the sheer number of O-Ag epitopes
found on the bacterial surface, which can run into millions. In-
terestingly, a single isotype, IgG2, is sufficient to account for this
inhibitory effect, yet this isotype is also known to be important for
protection to encapsulated bacteria and after immunization with
capsular polysaccharide vaccines (37, 38, 40, 41). In addition to
this there may be a role for the actual frequency that Ag is found.
In contrast to the predominance of LPS molecules on the bacterial
surface, OmpD is present at a much lower frequency (42) and so
any excess of Abs to this Ag may be less likely to be inhibitory.
Indeed, in studies examining the effect of infection with the hel-
minth N. brasiliensis on immunity observed to porins, a reduced
level of protection was observed associated with a reduced level of
IgG1 but not IgG2a to porins after immunization (27). The im-
portance of IgG1 seen in the current studies may therefore help
explain the reduced protection induced to porins in that model.
The Th1/Th2 bias in IgG switching observed in mice is not found
in humans because IgG isotypes in both species have evolved
independently (43). Nevertheless, there are some parallels be-
tween individual isotypes including structural homologies be-
tween the different isotypes. This is reflected in IgG isotypes
differing in their intrinsic flexibility and capacity to activate
complement. Murine IgG1 and human IgG2 are predicted to be
relatively rigid compared with other isotypes such as IgG2a in
mice and IgG1 in humans (44). Moreover, both human IgG2 and
murine IgG1 are relatively poor at activating human complement
(44). Because IgG1 and IgG2a differ in their intrinsic flexibility, it
is possible that this contributes to the Ab actually being able to
access the epitopes on the Ag surface. To understand this requires
the use of sophisticated modeling. Because anti-OmpD IgG2a
showed enhanced binding to whole bacteria when O-Ag was ab-
sent, it suggests that not all epitopes proximal to the bacterial
surface are accessible equally to all IgG isotypes because of oc-
clusion by LPS O-Ag. Indeed, this is supported by studies ex-
amining the protective role of IgG Abs of multiple isotypes
against LPS O-Ag (31).
This work shows the importance of inducing the appropriate
isotype to achieve the maximal efficacy of a vaccine. The wider
relevance of this is that the isotype induced to vaccines is more
controllable and open to modulation, through use of adjuvants and
the nature of the vaccine employed, than the Ab response observed
after natural infection. In parallel with the increased relevance of IgG
isotype in generating effective immunotherapies, it indicates that it is
time to renew our focus on the attributes of different forms of IgG.
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